| 臺大學術典藏 |
2022-03-04T03:48:18Z |
Titanium nanoparticle inhalation induces renal fibrosis in mice via an oxidative stress upregulated transforming growth factor-β pathway
|
Huang K.-T.; Wu C.-T.; Huang K.-H.; WEI-CHOU LIN; Chen C.-M.; Guan S.-S.; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:18Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
WEI-CHOU LIN; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; Jeng Y.-M.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:17Z |
The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old
|
Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; Wu V.-C.; Chueh S.-C.J.; Chen Y.-M.; Wu K.-D.; Wang M.-J.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chang C.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.; WEI-CHOU LIN; Hsieh B.-S.; TAIPAI group |
| 臺大學術典藏 |
2022-03-04T03:48:16Z |
Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study
|
Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; WEI-CHOU LIN; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:16Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; WEI-CHOU LIN; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:15Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chow P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-03-04T03:48:14Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.; Liu K.-L.; Chou P.-M.; WEI-CHOU LIN; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2022-03-04T03:48:13Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; WEI-CHOU LIN; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:08Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:07Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; WEI-CHOU LIN; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:07Z |
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
|
Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:06Z |
Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success
|
Peng K.-Y.; Liao H.-W.; Chan C.-K.; WEI-CHOU LIN; Yang S.-Y.; Tsai Y.-C.; Huang K.-H.; Lin Y.-H.; Chueh J.S.; Wu V.-C. |
| 臺大學術典藏 |
2022-03-04T03:48:06Z |
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
|
Chow P.-M.; Liu S.-H.; Chang Y.-W.; Kuo K.-L.; WEI-CHOU LIN; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:04Z |
CDK7 inhibition by THZ1 suppresses cancer stemness in both chemonaïve and chemoresistant urothelial carcinoma via the hedgehog signaling pathway
|
Chow P.-M.; Chang Y.-W.; Kuo K.-L.; WEI-CHOU LIN; Liu S.-H.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-01T08:19:47Z |
The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old
|
Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; Wu V.-C.; Chueh S.-C.J.; Chen Y.-M.; Wu K.-D.; MING-JIUH WANG; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chang C.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.; Lin W.-C.; Hsieh B.-S.; TAIPAI group |
| 臺大學術典藏 |
2022-02-15T03:45:47Z |
Primary aldosteronism and cerebrovascular diseases
|
ZHENG-WEI CHEN; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-02-15T03:45:45Z |
Endothelial dysfunction in primary aldosteronism
|
ZHENG-WEI CHEN; Tsai C.-H.; Pan C.-T.; Chou C.-H.; Liao C.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-02-15T03:45:45Z |
Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow-Up Study With Tissue Doppler Imaging
|
Chang Y.-Y.; Liao C.-W.; Tsai C.-H.; Chen C.-W.; Pan C.-T.; ZHENG-WEI CHEN; Chen Y.-L.; Lin L.-C.; Chang Y.-R.; Wu V.-C.; Wu K.-D.; Hung C.-S.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lian-Yu Lin M.D.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; on behalf of the TAIPAI Study Group* |
| 臺大學術典藏 |
2022-02-15T03:45:38Z |
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
|
Chan C.-K.; Chang Y.-Y.; Tsai Y.-C.; ZHENG-WEI CHEN; Wu C.-Y.; Huang W.-C.; Yen I.-W.; Wu K.-H.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; Lin L.-Y.; Hu F.-C.; Chang C.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Jeff Chueh S.-C.; Liao S.-C.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-01-17T08:00:31Z |
Predictive factors for ureteral double-J-stent-related symptoms: A prospective, multivariate analysis
|
Ho C.-H.; Tai H.-C.; Chang H.-C.; Hu F.-C.; Chen S.-C.; YUAN-JU LEE; Chen J.; Huang K.-H. |
| 臺大學術典藏 |
2022-01-17T08:00:31Z |
Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms
|
Ho C.-H.; Chen S.-C.; Chung S.-D.; YUAN-JU LEE; Chen J.; Yu H.-J.; Huang K.-H. |
| 臺大學術典藏 |
2022-01-17T08:00:29Z |
Pediatric urolithiasis in Taiwan: A nationwide study, 1997-2006
|
Huang W.-Y.; Chen Y.-F.; Chen S.-C.; YUAN-JU LEE; Lan C.-F.; Huang K.-H. |
| 臺大學術典藏 |
2022-01-17T08:00:28Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Moriya M.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:28Z |
Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy
|
YUAN-JU LEE; Huang K.-H.; Yang H.-J.; Chang H.-C.; Chen J.; Yang T.-K. |
| 臺大學術典藏 |
2022-01-17T08:00:26Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; YUAN-JU LEE; Huang K.-H.; Yu H.-J.; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2022-01-17T08:00:25Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; YUAN-JU LEE; Yu H.-J.; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; YUAN-JU LEE; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:23Z |
Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients
|
Liu K.-L.; Lee B.-C.; Ye J.-D.; Chang Y.-H.; Chang C.-C.; Huang K.-H.; YUAN-JU LEE; Chang Y.-C. |
| 臺大學術典藏 |
2022-01-17T08:00:22Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; YUAN-JU LEE; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2022-01-03T05:51:03Z |
Response to 'Diagnosis of aldosterone producing adenomas' [7]
|
Chung S.-D.; Wu V.-C.; Liu K.-L.; Huang K.-H.; SHIH-CHIEH CHUEH; Yu H.-J. |
| 臺大學術典藏 |
2022-01-03T05:49:25Z |
Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy
|
Lu C.-C.; Wu V.-C.; Wu K.-D.; Liu K.-L.; Lin W.-C.; Cheng M.-F.; Tzen K.-Y.; Yen R.-F.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; SHIH-CHIEH CHUEH; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2022-01-03T05:49:22Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; SHIH-CHIEH CHUEH; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2022-01-03T05:49:17Z |
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
|
Chan C.-K.; Chang Y.-Y.; Tsai Y.-C.; Chen Z.-W.; Wu C.-Y.; Huang W.-C.; Yen I.-W.; Wu K.-H.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; Lin L.-Y.; Hu F.-C.; Chang C.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; SHIH-CHIEH CHUEH; Liao S.-C.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2021-11-30T04:54:43Z |
Response to 'Diagnosis of aldosterone producing adenomas' [7]
|
Chung S.-D.; VIN-CENT WU; Liu K.-L.; Huang K.-H.; Chueh S.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-11-30T04:54:37Z |
Primary aldosteronism: Diagnostic accuracy of the losartan and captopril tests
|
VIN-CENT WU; Chang H.-W.; Liu K.-L.; Lin Y.-H.; Chueh S.-C.; Lin W.-C.; Ho Y.-L.; Huang J.-W.; Chiang C.-K.; Yang S.-Y.; Chen Y.-M.; Wang S.-M.; Huang K.-H.; Hsieh B.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:36Z |
Association of Kidney Function With Residual Hypertension After Treatment of Aldosterone-Producing Adenoma
|
VIN-CENT WU; Chueh S.-C.; Chang H.-W.; Lin L.-Y.; Liu K.-L.; Lin Y.-H.; Ho Y.-L.; Lin W.-C.; Wang S.-M.; Huang K.-H.; Hung K.-Y.; Kao T.-W.; Lin S.-L.; Yen R.-F.; Chen Y.-M.; Hsieh B.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:35Z |
131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results
|
Yen R.-F.; VIN-CENT WU; Liu K.-L.; Cheng M.-F.; Wu Y.-W.; Chueh S.-C.; Lin W.-C.; Wu K.-D.; Tzen K.-Y.; Lu C.-C.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-11-30T04:54:34Z |
Diagnosis of primary aldosteronism: Comparison of post-captopril active renin concentration and plasma renin activity
|
VIN-CENT WU; Kuo C.-C.; Chang H.-W.; Tsai C.-T.; Lin C.-Y.; Lin L.-Y.; Lin Y.-H.; Wang S.-M.; Huang K.-H.; Fang C.-C.; Ho Y.-L.; Liu K.-L.; Chang C.-C.; Chueh S.-C.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:29Z |
Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment
|
VIN-CENT WU; Kuo C.-C.; Wang S.-M.; Liu K.-L.; Huang K.-H.; Lin Y.-H.; Chu T.-S.; Chang H.-W.; Lin C.-Y.; Tsai C.-T.; Lin L.-Y.; Chueh S.-C.; Kao T.-W.; Chen Y.-M.; Chiang W.-C.; Tsai T.-J.; Ho Y.-L.; Lin S.-L.; Wang W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:28Z |
Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy
|
Lin Y.-H.; Huang K.-H.; Lee J.-K.; Wang S.-M.; Yen R.-F.; VIN-CENT WU; Chung S.-D.; Liu K.-L.; Chueh S.-C.; Lin L.-Y.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Chang H.-W.; Hu F.-C.; Chen Y.-M.; Kuo C.-C.; Lu C.-C.; Chang F.-C.; Liao S.-C.; Lin W.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-11-30T04:54:27Z |
The association of serum potassium level with left ventricular mass in patients with primary aldosteronism
|
Lin Y.-H.; Wang S.-M.; VIN-CENT WU; Lee J.-K.; Kuo C.-C.; Yen R.-F.; Liu K.-L.; Huang K.-H.; Chueh S.-C.; Wang W.-J.; Lin L.-Y.; Chien K.-L.; Ho Y.-L.; Chen M.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:26Z |
Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism
|
Kuo C.-C.; VIN-CENT WU; Tsai C.-W.; Huang K.-H.; Wang S.-M.; Li B.-C.; Chang C.-C.; Lu C.-C.; Yang W.-S.; Chao C.-T.; Tsai I.-C.; Lai C.-F.; Lin W.-C.; Wu M.-S.; Lin Y.-H.; Lin C.-Y.; Chang H.-W.; Wang W.-J.; Chiang W.-C.; Kao T.-W.; Chueh S.-C.; Chu T.-S.; Tsai T.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:26Z |
Kidney impairment in primary aldosteronism
|
VIN-CENT WU; Yang S.-Y.; Lin J.-W.; Cheng B.-W.; Kuo C.-C.; Tsai C.-T.; Chu T.-S.; Huang K.-H.; Wang S.-M.; Lin Y.-H.; Chiang C.-K.; Chang H.-W.; Lin C.-Y.; Lin L.-Y.; Chiu J.-S.; Hu F.-C.; Chueh S.-C.; Ho Y.-L.; Liu K.-L.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:25Z |
Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)
|
Kuo C.-C.; VIN-CENT WU; Huang K.-H.; Wang S.-M.; Chang C.-C.; Lu C.-C.; Yang W.-S.; Tsai C.-W.; Lai C.-F.; Lee T.-Y.; Lin W.-C.; Wu M.-S.; Lin Y.-H.; Chu T.-S.; Lin C.-Y.; Chang H.-W.; Wang W.-J.; Kao T.-W.; Chueh S.-C.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:22Z |
Recurrence of primary aldosteronism after percutaneous ethanol injection
|
Chang F.-C.; Liu K.-L.; Huang K.-H.; VIN-CENT WU; Lin Y.-H.; Chen Y.-M.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:14Z |
Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
|
Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; VIN-CENT WU; Wu K.-D.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-11-30T04:54:10Z |
Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy
|
Lu C.-C.; VIN-CENT WU; Wu K.-D.; Liu K.-L.; Lin W.-C.; Cheng M.-F.; Tzen K.-Y.; Yen R.-F.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chueh S.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
